🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations and gratitude to the #JACC:HF editorial board, contributors, reviewers, staff. Proud to report that our IF is the highest among HF journals,ranks us among the top 10 CV journals! Akshay Desai Shelley Zieroth Minnow Walsh, MD, MACC Anita Deswal Paul Heidenreich Sean Pinney

Thanks to the entire JCF community for supporting the growing impact of the journal - onward and upward we go. Together. Anu Lala-Trindade Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Andrew J Sauer MD Nosheen Reza, MD, MS Jason N. Katz HFSA Michael Felker

Pleased to share our work—frailty is prevalent and strongly impacts cath lab outcomes especially in complex PCI. Ajar Kochar @jennifer_rymer Michael Nanna TCTMD JACC Journals Dr. Deepak L. Bhatt

Congrats to @AnkeetBhattMD and the KP-VACCINATE team! ~4 million adults randomized in 4 weeks—the largest RCT ever fully embedded in a LHS. Testing CV-focused vs. usual care messaging to improve flu vaccination. Results soon. (sciencedirect.com/science/articl…). Tor Biering-Sørensen, MD, MSc, MPH, PhD Muthu Vaduganathan

PAH leads to muscle atrophy through inflammation, poor perfusion, and protein imbalance—driving symptoms like dyspnea and exercise intolerance. This review explores molecular drivers of muscle loss and the potential of exercise to counteract (link.springer.com/article/10.100…). #HREV

A noninvasive wearable (CardioTag) estimated PCWP in HFrEF patients with accuracy approaching implantable sensors (CardioMEMS). This low-cost, scalable approach could transform remote hemodynamics-guided HF care! (sciencedirect.com/science/articl…) Liviu Klein Marat Fudim, MD MHS Cardiosense

Obesity drives a unique, early-onset form of HFpEF—often underdiagnosed. Yet, no guidelines recommend screening. This review outlines why systematic screening in obesity is overdue and proposes a tailored approach (link.springer.com/article/10.100…). #HREV Josephine Harrington, MD Marat Fudim, MD MHS

Just published in the JACC Journals: Results from the 15-site SEISMIC-HF I study demonstrate the power of Cardiosense’s AI algorithm to noninvasively estimate cardiac filling pressures on par with implantable sensors. The full results in #JACCHF ▶️sciencedirect.com/science/articl…

New tech alert! A wearable sensor (CardioTag) + advanced ML model estimates Pulmonary Capillary Wedge Pressure, key for heart failure, non-invasively. Tested against invasive measures, it showed strong correlation, opening doors for remote HF management sciencedirect.com/science/articl…

25 years ago today I started my first day of intern year at StanfordMedRes — fittingly in the CCU. Today we welcome a new group of interns beginning their journey on their first day, the 16th (!) time I have been able to do so as PD. Grateful for the 25 years of memories! 🎂

📊 The KP CHAGAS Study (thepermanentejournal.org/doi/10.7812/TP…): Largest U.S.-based experience of Chagas in the community. 🧬 Diagnoses tripled from 2006–2022. Many patients presented late, with high rates of HF, transplant, and CV death. Congrats to Salvador Hernandez, MD and team! Kaiser Permanente NorCal Cardiology Fellowship

Interconnected pathways and emerging therapies in chronic kidney disease and heart failure: in-depth review Exec Service Corps (E.S.C.) Heart Failure ow.ly/IAkJ50WgPEx EJHF Editor-in-Chief Jan Biegus @Ppponikowski #HFA_ESC Harriette Van Spall, MD MPH 🇨🇦 Shelley Zieroth Marat Fudim, MD MHS Gregg Fonarow MD Alexandre Mebazaa Marco Metra Gianluigi Savarese

🚨Two new JACC Advances papers drop today linking SGLT2 inhibitors ↔ apolipoprotein M (ApoM) across very different settings—ambulatory HFrEF (DEFINE-HF) and acute inflammation (LPS-sepsis & COVID-19). Let’s unpack why this kidney-liver-vascular axis matters. A 🧵 1️⃣/15

Mid-Atlantic Permanente Medicine was well represented at the fantastic #NYvalves25 conference. Great to be speaking on same panel as Noah Haroian, MD PharmD to discuss complex mitral interventions and highlight innovative approaches we use to address challenging anatomy at MAPMG. Cardiovascular Research Foundation Kaiser Permanente

Chagas Disease (CD) is a neglected tropical condition. We reviewed data from 2006–2022 it revealed that CD tripled during that period in KPNCAL 🚨Many cases were caught late—when patients already had heart failure, needed a transplant, or had CV death thepermanentejournal.org/doi/10.7812/TP…

Athlete’s heart vs. cardiomyopathy—where’s the line? 🫀 This review breaks down how to distinguish physiologic remodeling from early-stage hypertrophic, dilated, or arrhythmogenic CM using imaging. A practical guide to navigating the “gray zone” (link.springer.com/article/10.100…). #HREV

AF and HFpEF co-exist and drive CV risk. Managing AF in HFpEF requires an integrated approach—HF therapy, rhythm or rate control, and stroke prevention. There is a growing case for early rhythm control via ablation (link.springer.com/article/10.100…). #HREV Paula Rambarat Jonathan Piccini, MD, MHS

The July issue Journal of Cardiac Failure is out! This month we welcome our new #FunctionNotFailure trainees as well as those in all 🫀disciplines! Sharing thoughts on the #zen notion of a #BeginnersMind 👇🏽👇🏽👇🏽 whether a new trainee or well advanced in career… Robert Mentz, MD

The gut-heart axis plays a key role in HF. Gut microbiota differ by HF stage and cause—shaped by meds, transplants, and devices. Metabolites like TMAO & SCFAs may drive HF via immune pathways. A new review explores the evidence (link.springer.com/article/10.100…). #HREV Robert Huang

Fewer than 1% of eligible HF patients receive implantable monitors. A new JACC:HF editorial highlights how CardioTag may change that—by reducing barriers, scaling access, and performing across diverse subgroups. Read the review: jacc.org/doi/10.1016/j.…